Nasca M R, Micali G, Pulvirenti N, Licastro Cicero R
Clinica Dermatologica, Università di Catania, Piazza S. Agata La Vetere 6, 95124 Catania, Italy.
Eur J Dermatol. 1998 Mar;8(2):125-6.
One of the possible unwanted side effects following contact immunotherapy of alopecia areata is skin hypopigmentation, either in the form of a transient, post-inflammatory hypopigmentation or as the development of a persistent, depigmented patch. A case of leucoderma occurring on the forehead of a 16-year-old girl following application of squaric acid dibutylester to the scalp for the treatment of alopecia areata is described. Past medical and family history were negative for vitiligo and autoimmune disorders. The hypopigmented patch was distant from the scalp area where squaric acid dibutylester had been applied, and it was not preceded by any sign of eczema, erythema or itch in the same area. Moreover, it faded as soon as treatment was discontinued. A 4-year follow-up revealed no evidence of vitiligo. In conclusion, the possible occurrence of a transient leucoderma in untreated areas should be included among the side effects of contact immunotherapy of alopecia areata with squaric acid dibutylester.
斑秃接触免疫疗法可能产生的不良副作用之一是皮肤色素减退,表现为一过性的炎症后色素减退,或发展为持久性的色素脱失斑。本文描述了一名16岁女孩,在头皮应用二丁基癸二酸酯治疗斑秃后,前额出现白斑的病例。既往病史及家族史均无白癜风及自身免疫性疾病。色素减退斑远离应用二丁基癸二酸酯的头皮区域,且该区域之前没有任何湿疹、红斑或瘙痒迹象。此外,一旦停止治疗,色素减退斑就会消退。4年随访未发现白癜风迹象。总之,使用二丁基癸二酸酯进行斑秃接触免疫疗法的副作用应包括在未治疗区域可能出现一过性白斑。